Has Dean Klug, MD received payments from drug or device companies?

Yes. Drug and device makers reported $37,398 in general payments to Dean Klug, MD across 203 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dean Klug, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dean Klug, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dean Klug, MD

Otolaryngology · Germantown, TNNPI 1265548713

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $26,274 of the $37,398 with a category attached, or 70.3%. Regeneron Healthcare Solutions, Inc. accounts for 75.3% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $21,502, more than ten times the $948 reported in 2019. Among otolaryngology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,398in general payments, 2019–2025

Across 203 payments — averaging $184.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$28K
Aerin Medical Inc.$2K
Sanofi$2K
Acclarent, Inc$2K
Medical Device Business Services, Inc.$946
Integra Lifesciences Corporation$722
plus $2K from 16 others

What the payments were for

Speaking & faculty fees$26,27470%
Travel & lodging$3,4889%
Food & beverage$7,58120%
Education$550%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	17	$28,154
Aerin Medical Inc.	16	$2,337
Sanofi	66	$1,757
Acclarent, Inc	32	$1,664
Medical Device Business Services, Inc.	7	$946
Integra Lifesciences Corporation	12	$722
Intersect ENT, Inc.	6	$455
GSK	19	$366
Medtronic(2 entities)	6	$250
AbbVie(2 entities)	5	$194
Neurent Medical Limited	2	$174
Optinose US, Inc.	3	$75
Stryker	1	$58
Sanofi-aventis U.S. LLC	1	$55
Kowa Pharmaceuticals America, Inc.	2	$43
AstraZeneca	2	$35
Smith+Nephew	1	$29
Hologic Sales And Service, LLC	1	$25
Baxter Healthcare	1	$23
Hikma Pharmaceuticals USA	1	$15
Merck	1	$13
Genentech USA, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$28,023
VIVAER STYLUS$2,020
RHINAER STYLUS$691
Acclarent Aera$379
Inspira Air$379
RELIEVA SPINPLUS NAV$379
TruDi Probe$379
PROPEL$256
NEUROMARK Device$139
NEUROMARK Radiofrequency Console$139
SINUVA$136
Relieva Ultirra$134
Relieva Spinplus$114
RELIEVA SPINPLUS Balloon Sinuplasty System$110

How this compares

$37,398 in reported general payments places this provider in the 95th percentile of 191 otolaryngology providers in Tennessee.

See all otolaryngology providers in Tennessee →

Medicare billing

Part B allowed, 2024

$148,042

Medicare patients

288

Services billed

1,775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	152	$3,992
Cefdinir	90	$2,478
Montelukast Sodium	364	$2,109
Fluticasone Propionate	81	$1,077
Ipratropium Bromide	23	$784
Omeprazole	48	$462
Mupirocin	63	$425
Methylprednisolone	40	$280
Ondansetron OdtOndansetron	37	$252
Azithromycin	44	$237
Clotrimazole	11	$233
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	31	$169
Prednisone	49	$152
Famotidine	16	$74
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid	16	$52

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Germantown

Brandon ShepherdGermantown$7K
John TouliatosGermantown$5K
Rakesh ChandraNashville$381K
David FortuneHermitage$298K
Grady BryantHermitage$74K
Marion GillespieMemphis$67K
Clyde MathisonFarragut$66K
Michael TopfNashville$36K
John GleysteenMemphis$25K
Allan RosenbaumPowell$21K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →